Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Support from Sanofi-Aventis, Roche Pharma and Pfizer
Woman Max 99 years
Support from Sanofi-Aventis, Roche Pharma and Pfizer
Update Il y a 4 ans
A randomised phase II study of cytotoxic chemotherapy or cytotoxic chemotherapy combined with celecoxib or trastuzumab as primary chemotherapy for patients with high risk localised breast cancer not amenable to breast conserving therapy
Not provided at time of registration
Country
France
organs
None
Specialty
None
Closed trial
More information